Chelation Treatment for Autism Spectrum Disorders: A Systematic Review.

[1]  N L Smith,et al.  The certainty of judgments in health evaluations. , 1981, Evaluation and program planning.

[2]  D. Moel,et al.  Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels. , 1982, Pediatrics.

[3]  D. Bailey,et al.  Evaluating Programme Impact: Levels of Certainty , 1991 .

[4]  T. Eppright,et al.  Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. , 1996, Missouri medicine.

[5]  Eppright Td,et al.  Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. , 1996 .

[6]  A. Wakefield,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.

[7]  A. Sabrá,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.

[8]  Richard Simpson,et al.  Interventions for Children and Youth with Autism , 1998 .

[9]  Larry J. Anderson,et al.  Morbidity and Mortality Weekly Report , 2002 .

[10]  Lorna Wing,et al.  The epidemiology of autistic spectrum disorders: is the prevalence rising? , 2002, Mental retardation and developmental disabilities research reviews.

[11]  B. Schwartz,et al.  Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data , 2004, Pediatrics.

[12]  R. Jacobson.  Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine – A systematic review of current epidemiological evidence , 2004 .

[13]  J. Risher,et al.  Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. , 2005, Neurotoxicology.

[14]  B. Schwartz,et al.  Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data , 2005, Pediatrics.

[15]  Richard D. Leiker,et al.  Deaths Resulting From Hypocalcemia After Administration of Edetate Disodium: 2003-2005 , 2006, Pediatrics.

[16]  Lawrence Rosen,et al.  Parental Perceptions and Use of Complementary and Alternative Medicine Practices for Children with Autistic Spectrum Disorders in Private Practice , 2006, Journal of developmental and behavioral pediatrics : JDBP.

[17]  D. Geier,et al.  A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. , 2006, Neuro endocrinology letters.

[18]  A. Doja,et al.  Immunizations and Autism: A Review of the Literature , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[19]  Jeff Sigafoos,et al.  Internet survey of treatments used by parents of children with autism. , 2006, Research in developmental disabilities.

[20]  Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005. , 2006, MMWR. Morbidity and mortality weekly report.

[21]  M. Strawderman,et al.  Succimer Chelation Improves Learning, Attention, and Arousal Regulation in Lead-Exposed Rats but Produces Lasting Cognitive Impairment in the Absence of Lead Exposure , 2006, Environmental health perspectives.

[22]  L. Curtis,et al.  A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: a prepilot study. , 2007, Journal of alternative and complementary medicine.

[23]  M. Mitka.  Chelation therapy trials halted. , 2008, Journal of the American Medical Association (JAMA).

[24]  Andrea Hensley,et al.  Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results , 2009, BMC clinical pharmacology.

[25]  Andrea Hensley,et al.  Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results , 2009, BMC clinical pharmacology.

[26]  M. Ireland,et al.  Complementary Alternative Medicine for Children with Autism: A Physician Survey , 2009, Journal of autism and developmental disorders.

[27]  Andres F Zuluaga,et al.  Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics , 2009, BMC clinical pharmacology.

[28]  Hatice Günayer Şenel.  Parents’ Views and Experiences About Complementary and Alternative Medicine Treatments for Their Children with Autistic Spectrum Disorder , 2010, Journal of autism and developmental disorders.

[29]  M. O'Reilly,et al.  Gluten-free and casein-free diets in the treatment of autism spectrum disorders: a systematic review , 2010 .

[30]  Lora D. Delwiche,et al.  Blood Mercury Concentrations in CHARGE Study Children with and without Autism , 2009, Environmental health perspectives.

[31]  T. Lancet,et al.  Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 2010, The Lancet.

[32]  J. Baio.  Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.

[33]  S. Edelson,et al.  Autism Treatment Evaluation Checklist , 2012 .

[34]  Intervention and Treatment , 2018, False Messengers.